Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
54,711,345
-
Total 13F shares
-
33,480,528
-
Share change
-
+752,167
-
Total reported value
-
$948,106,901
-
Price per share
-
$28.32
-
Number of holders
-
63
-
Value change
-
+$22,388,815
-
Number of buys
-
38
-
Number of sells
-
15
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q4 2019
As of 31 Dec 2019,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,480,528 shares.
The largest 10 holders included
Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, GILDER GAGNON HOWE & CO LLC, Cormorant Asset Management, LP, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Redmile Group, LLC, BlackRock Inc., FEDERATED HERMES, INC., and VANGUARD GROUP INC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.